AltruBio is developing first-in-class immunomodulators to target diseases of the immune system. Our world-class global team brings a breadth of expertise in immunology and drug development to bring our biologic treatments to patients.
AltruBio's senior management is built on a team of individuals possessing strong academic and drug development knowledge, high-level managerial experience and scientific expertise in a range of fields including life science research in immunology, translational sciences, clinical development, technical development, regulatory affairs, financial operation and business development.
b2/20220119085816jfyqzzCp68.png)
Judy Chou, Ph.D.
President and Chief Executive Officer, Chairperson of AltruBio Taiwan Inc.
b2/20220119085817sjvx53Cae11.png)
Ping-Yang, Yeh, Ph.D.
President of AltruBio Taiwan Inc.
b2/20220119085815fmusyhuTo3.png)
Gene Lee, Ph.D.
Chief Technical Officer
b2/20220119085814hm9togcUw2.png)
Shih-Yao Lin, MD., Ph.D.
Vice President of Research
b2/20220119085816lalxioIK49.png)
Leewen Lin, Ph.D., LL.M.
Vice President of Legal Affairs
b2/20220119085817euwtdxDul13.png)
Simona Reed, Ph.D.
Vice President of Clinical Program Management
b2/2025050510181223o6bd9a81.jpg)
Adrian Serone, Ph.D.
Vice President of Corporate Program Lead
b2/20250108163436ik6ev4QIO1.png)
Edwin Powers
Vice President of Business Strategy and Development
b2/20220404232604a864uv53T1.png)
Stephen G. Juelsgaard, D.V.M., J.D.
Chairperson of the Board
b2/20220119085816bxkhawFF612.png)
Sean P. Bohen, M.D., Ph.D.
b2/202408011020181qdfmkYsX1.jpg)
Tomer Berkovitz, PhD
Judy Chou, Ph.D.
President and Chief Executive Officer, Chairperson of AltruBio Taiwan Inc.
b2/2022011909321298gqakCig1.png)
John Doyle
b2/20220119085814wycs59cLB1.png)
Corsee Sanders, Ph.D.
b2/20220119085816pqgb3iAiV10.png)
Patrick Y. Yang, Ph.D.
Vijay K Kuchroo, DVM, Ph.D., Chair of the Scientific Advisory Board
Samuel L. Wasserstrom Professor of Neurology, Harvard Medical School
Senior Scientist, Brigham and Women’s Hospital
Investigator, Klarman Cell Observatory
Founding Director, The Gene Lay Institute
Fu-Tong Liu, M.D., Ph.D.
Professor of Clinical Dermatology, University Southern California.
Bernard Malissen, Ph.D.
Founder and Director, the immunophenomics Center (CIPHE, INSERN-CNRS)
Philip J. Mease, M.D.
Director of the Rheumatology Research Division at Swedish Medical Center/ Providence St. Joseph Health
Clinical Professor of Medicine at the University of Washington in Seattle.
Walter Reinisch, M.D.
Director of the Inflammatory Bowel Disease Study Group, Medical University of Vienna
David T. Rubin, MD, AGAF, FACG, FASGE, FACP
Joseph B. Kirsner Professor of Medicine at University of Chicago
Arlene Sharpe, M.D., Ph.D.
Kolokotrones University Professor, Harvard University
Chair of the Department of Immunology, Harvard Medical School
Vice Director, the Gene Lay Institute